当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Liang Chen
Seasonal influenza vaccination plays a crucial role in reducing the burden of illness and mortality associated with influenza outbreaks. However, despite a positive trend in vaccine usage, the benefits of vaccination are limited due to vaccine complacency and dose distribution inequities. Vaccine complacency refers to a diminishing sense of urgency or importance placed on vaccination, while dose distribution inequities result in certain populations facing barriers in accessing vaccines. This article explores the importance of addressing these challenges to maximize the impact of seasonal influenza vaccination. It emphasizes the need for robust education campaigns to combat vaccine complacency and dispel myths surrounding the vaccine. Additionally, targeted strategies are required to address dose distribution inequities, including equitable vaccine allocation, expanded access points, and subsidized or free vaccines. Strengthening vaccine confidence and access through transparent communication, technology utilization, and collaboration between stakeholders is essential. By closing the gap in complacency and inequities, we can ensure that seasonal influenza vaccination is effective and accessible to all, thus improving public health outcomes.